Search Results

You are looking at 1 - 1 of 1 items for :

  • "thyroid cancer" x
  • Pituitary and Hypothalamus x
Clear All
Ichelle Maa van Roessel Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Ichelle Maa van Roessel in
Google Scholar
PubMed
Close
,
Boudewijn Bakker Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Boudewijn Bakker in
Google Scholar
PubMed
Close
,
Hanneke M van Santen Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Close
, and
Wassim Chemaitilly Division of Pediatric Endocrinology, UPMC Children’s Hospitalof Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Wassim Chemaitilly in
Google Scholar
PubMed
Close

thyroid hormones, high enough to suppress TSH values (TSH suppressive therapy), are used in order to limit the growth of potential residual thyroid cancer cells in the postoperative management of patients with differentiated thyroid carcinoma ( 34 ). It is

Open access